BamSEC and AlphaSense Join Forces
Learn More

Pliant Therapeutics Inc. – Indentures

NASDAQ: PLRX    
Share price (6/2/26): $1.16    
Market cap (6/2/26): $71.8 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from S-3 41 pages Pliant Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ], 202[ ] Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 41 pages Pliant Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ], 202[ ] Senior Debt Securities
12/34/56
EX-4.2
from 10-K 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 5 pages Amendment to Stockholder Rights Agreement
12/34/56
EX-4.1
from 8-A12B 73 pages Stockholder Rights Agreement Pliant Therapeutics, Inc. and Computershare Trust Company, N.A., as Rights Agent Dated as of March 12, 2025
12/34/56
EX-4.10
from S-3ASR 53 pages Pliant Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20[•] Subordinated Debt Securities
12/34/56
EX-4.9
from S-3ASR 52 pages Pliant Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20[•] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 99 pages Pliant Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement December 19, 2019 Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS/A 99 pages Pliant Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement December 19, 2019 Amended and Restated Investors’ Rights Agreement
12/34/56